Editorial policy

Every page on GLP Atlas follows the same process. The goal is simple: accurate, current, label-based information you can check yourself.

Sources we use

• FDA prescribing information (DailyMed and Drugs@FDA) and the Health Canada Drug Product Database.
• Manufacturer press releases for approvals, launches and self-pay prices.
• Peer-reviewed trials and registered studies on ClinicalTrials.gov.

Review and dates

• Each drug page is reviewed by a licensed clinician before publication and on every major update. The reviewer's name and date appear on the page.
• Pages carry a "last reviewed" date and are re-checked when labels or prices change.
• Dosing is reproduced from the label only. Insulin doses are never given as numbers, because they are always individual.

Independence

• Commercial partners never see or approve content before publication.
• We do not accept payment to rank, praise or omit any product.

Corrections

Email contact@glpatlas.com. We respond within 5 business days, fix confirmed errors and update the review date.